Company Filing History:
Years Active: 2012
Title: Claude Schaerer: Innovator in Enantioselective Synthesis
Introduction
Claude Schaerer is a notable inventor based in Gelterskinden, Switzerland. He has made significant contributions to the field of chemistry, particularly in the area of enantioselective synthesis. His work has implications for the development of pharmaceuticals and other chemical products.
Latest Patents
Schaerer holds a patent for the "Enantioselective synthesis of γ-amino-αβ-unsaturated carboxylic acid derivatives." This patent describes a palladium-catalyzed method for the preparation of these derivatives, which are important in various chemical applications. The innovative approach outlined in his patent enhances the efficiency and selectivity of the synthesis process.
Career Highlights
Claude Schaerer is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to work on cutting-edge research and development projects. His expertise in enantioselective synthesis has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Schaerer has collaborated with esteemed colleagues, including Murat Acemoglu and Andreas Pfaltz. These collaborations have fostered a productive research environment, leading to advancements in their respective fields.
Conclusion
Claude Schaerer is a distinguished inventor whose work in enantioselective synthesis has made a significant impact in the field of chemistry. His contributions continue to influence the development of innovative chemical processes.